Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2023 | 08-2023 | 05-2023 | 02-2023 | 11-2022 | |
| Sales | 151 | -3 | 93 | 35 | 101 |
| Cost of Goods | 5 | 0 | 13 | 3 | 16 |
| Gross Profit | 146 | -3 | 80 | 32 | 86 |
| Operating Expenses | 1,286 | 1,067 | 2,464 | 1,343 | 1,855 |
| Operating Income | -1,139 | -1,071 | -2,384 | -1,311 | -1,769 |
| Other Income | -46 | -179 | 0 | 0 | 0 |
| Pre-tax Income | -1,185 | -1,249 | -2,384 | -1,311 | -1,769 |
| Net Income Continuous | -1,185 | -1,249 | -2,384 | -1,311 | -1,769 |
| Minority Interests | 6 | 10 | 12 | 13 | 13 |
| Net Income | $-1,179 | $-1,239 | $-2,372 | $-1,298 | $-1,756 |
| EBITDA(a) | $-1,110 | $-1,000 | $-2,359 | $-1,286 | $-1,745 |